SLC9A1 and prostate cancer: Androgen-insensitive DU145 prostate cancer cells showed an elevated expression of both NHE1 and V-ATPase proton pumps at both mRNA and protein levels, comparable to that of other androgen-insensitive PC3 cancer cells (Supplementary Figure S2).